HematologyVideos + slides2025
Brigham and Dana-Farber Board Review in Hematology 2025 — benign and malignant haematology in 34 lectures
Where most hem-onc reviews rush the non-malignant chapters, The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology 2025 gives them half the programme. Its 34 recorded talks (with slides, released 15 March 2025) pair a full leukaemia, myeloma and lymphoma block with dedicated sessions on marrow failure, anaemias, haemoglobinopathies, platelets, bleeding, thrombosis and transfusion, taught by 33 Boston faculty.
- 34lectures
- 33faculty
- 17classical haematology talks
- 2025release
What you’ll be able to do
- Work up anaemia, from iron deficiency and overload to immune and non-immune haemolysis
- Manage sickle cell disease and thalassaemia with current approaches
- Separate acquired and congenital marrow failure, and recognise HLH
- Evaluate thrombocytopenia, haemophilia and von Willebrand disease
- Handle thrombophilia and cancer-associated venous thrombosis and order blood products wisely
Inside the course
Shared opening and malignant haematology
Seventeen lectures cover cancer genetics, infections, opioid use, end-of-life communication, stem cell transplant biology, acute leukaemia, MDS, CML, MPNs, myeloma, Waldenström macroglobulinaemia, the lymphomas and CLL.
Marrow and red cells
David Sykes on haematopoiesis and cytokines, Julie-Aurore Losman and Grant Rowe on acquired and congenital marrow failure, then an anaemia overview, iron, both haemolytic anaemia talks, sickle cell disease and haemoglobinopathies.
Brigham and Dana-Farber Board Review in Hematology: bleeding and clotting
Nancy Berliner on neutrophil disorders precedes acquired thrombocytopenias, haemophilia, von Willebrand and platelet disorders, thrombophilia and Jean Connors on difficult venous thrombosis in cancer.
Transfusion for clinicians
Marie Hollenhorst closes with a practical transfusion medicine session aimed at the prescribing physician rather than the blood bank.
Built for
- Fellows sitting the ABIM hematology examClassical haematology gets real depth, not a single survey talk.
- Consultative haematologistsRefresh benign referrals — cytopenias, bleeding, clots — seen every week.
- Internists and hospitalistsAnaemia, thrombosis and transfusion talks translate straight to the ward.
Faculty & syllabus
Lectures and faculty 34 lectures
- Marios Giannakis, MD, PhD — Molecular Genetics of Cancer
- Lindsey Baden, MD — Infections in Cancer Patients
- Kate M. Lally, MD — Opioid Prescribing for Cancer-Related Pain
- Eilann C. Santo, MD, MPH — Communication – The Key to Excellence in End-of-Life Care
- Robert J. Soiffer, MD — Biology of Hematopoietic Stem Cell Transplantation
- Zuzana Tothova, MD, PhD — Biology of Acute Leukemia and Myelodysplastic Syndromes
- Daniel J. DeAngelo, MD, PhD — The Evolving Treatment Landscape of the Acute Leukemias – Where Are We Now
- Eric S. Winer, MD — Myelodysplastic Syndrome
- Marlise R. Luskin, MD — Chronic Myelogenous Leukemia
- Joan-Chi How, MD — Myeloproliferative Syndromes
- Kenneth C. Anderson, MD — Multiple Myeloma
- Jorge J. Castillo, MD — Waldenstrom Macroglobulinemia and Amyloidosis
- Caron A. Jacobson, MD — Low Grade Lymphomas
- Eric D. Jacobsen, MD — Agressive Non-Hodgkin Lymphoma Part 1 – Diffuse Large B-Cell and Burkitt
- Eric D. Jacobsen, MD — Agressive Non-Hodgkin Lymphoma Part 2 – Mantle Cell and T-Cell
- Reid W. Merryman, MD — Hodgkin's Lymphoma
- Matthew S. Davids, MD — Diagnosis and Treatment of CLL and Related B-Cell Malignancies
- David B. Sykes, MD, PhD — Hematopoiesis and Cytokines
- Julie-Aurore Losman, MD, PhD — Acquired Bone Marrow Failure
- Grant Rowe, MD, PhD — Congenital Bone Marrow Failure
- Sarah Nikiforow, MD — HLH
- Robert Stern, MD — Anemia – An Overview
- Mark D. Fleming, MD, Dphil — Iron Deficiency and Iron Overload
- Arielle L. Langer, MD, MPH — Immune Hemolytic Anemia
- David E. Golan, PhD, MD — Non-immune Hemolytic Anemia
- Maureen M. Achebe, MD, MPH — Sickle Cell Disease
- Matthew M. Heeney, MD — Thalassemia and Other Hemoglobinopathies
- Nancy Berliner, MD — Disorders of Neutrophils
- Elisabeth M. Battinelli, MD, PhD — Acquired Thrombocytopenias
- Stacy E. Croteau, MD — Hemophilia
- Nathan T. Connell, MD, MPH — Von Willebrand Disease and Congenital Platelet Disorders
- Kenneth A. Bauer, MD — Congenital and Acquired Thrombophilia
- Jean M. Connors, MD — Managing Challenging Cases of Venous Thrombosis in Patients with Cancer
- Marie A. Hollenhorst, MD, PhD — Transfusion Medicine for the Clinician
Before you buy
Do I need the Brigham oncology 2025 review as well?
Only for solid tumours. Seventeen of these 34 lectures are identical to those in the Brigham and Dana-Farber oncology 2025 edition (MS-22117); the classical haematology half appears only here.
What format are the talks?
Video recordings accompanied by the presenters’ slides; no question bank is included.
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | Video lectures with slides |
|---|---|
| Contents | 34 lectures · 33 faculty |
| Released | 15 March 2025 |
| Publisher | Brigham and Women’s Hospital · Dana-Farber |
| Department | Oncology |
| Delivery | Instant download · lifetime re-download |
Related products
Harvard Medicine
Harvard Psychosocial Oncology — What to Expect When Caring for an Oncology Patient 2026
Harvard Medicine
Cardiology
Critical Care / Emergency Medicine
Harvard Critical Issues in Tumor Microenvironment Angiogenesis, Metastasis and Immunology 2025
Oncology-Hematology
The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology 2025 (Videos + Slides)